Zilarvir (GPO)
2084
indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) infection

2084
indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) infection
